Volume 6, Issue 9, Pages (September 2009)

Slides:

Advertisements

Similar presentations

Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation.

Advertisements

Volume 12, Issue 6, Pages (June 2015)

Volume 14, Issue 10, Pages (October 2017)

Volume 12, Issue 7, Pages (July 2015)

Cardiac ion channels in health and disease

One tachycardia with two entrainment responses: What is the mechanism?

Volume 13, Issue 11, Pages (November 2016)

Volume 7, Issue 9, Pages (September 2010)

Volume 13, Issue 2, Pages (February 2016)

Ventricular Arrhythmias

Volume 11, Issue 1, Pages (January 2014)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 13, Issue 1, Pages (January 2016)

Volume 9, Issue 4, Pages (April 2012)

Ellis Rochelson, MD, Lynn Nappo, RN, Robert H. Pass, MD

Volume 11, Issue 1, Pages (January 2014)

Ventricular Tachycardia in Structural Heart Disease

James R. Edgerton, MD, Cecile Mahoney, BS, Michael J

Volume 11, Issue 2, Pages (February 2014)

Volume 13, Issue 5, Pages (May 2016)

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome Yasuaki.

Recurrent commotio cordis: Déjà vu

Volume 4, Issue 2, (February 2007)

Correlation between functional and ultrastructural substrate in Brugada syndrome Pablo E. Tauber, MD, Virginia Mansilla, MD, Guillermo Mercau, MD, Felix.

Volume 7, Issue 11, (November 2010)

Epicardial substrate ablation for Brugada syndrome

Is it bradycardia or something else causing symptoms?

Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome Laura Halperin, BSc, Greg Mellor, MD, Mario.

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome

Elderly man with ICD shocks

Volume 11, Issue 6, Pages (June 2014)

Volume 16, Issue 1, Pages e3-e16 (January 2019)

HeartRhythm Case Reports

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient Isla McClelland, MD,

General anaesthesia in a patient with Brugada syndrome

Local activation delay exacerbates local J-ST elevation in the epicardium: Electrophysiological substrate in Brugada syndrome Naoya Kataoka, MD, PhD,

Repeated molecular genetic analysis in Brugada syndrome revealed a novel disease- associated large deletion in the SCN5A gene Anders Krogh Broendberg,

Atrial pacing for the management of ventricular arrhythmias in Andersen-Tawil syndrome Opeyemi Fadahunsi, MBBS, MPH, Bilal Shaikh, DO, Andrew Rettew,

Jonathan T. Jaffe, MD, Lee-Gardie Jean, MD, Richard J. Murray, MD

Volume 14, Issue 12, Pages (December 2017)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy Jayaprakash.

Michael R. Gold, MD, PhD, FHRS Heart Rhythm

Kevin M. W. Leong, MBBS, MRCP, Henry Seligman, MBBS, MRCP, Amanda M

An inferior myocardial infarction with conduction abnormalities

Expanding the electrical phenotype of NKX2-5 mutations: Ventricular tachycardia, atrial fibrillation, and complete heart block within one family Simone.

Who is the guilty among these two silent killers?

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome Shaobo Shi, MD, PhD, Tao Liu, MD, PhD,

Simrit K. Warring, MS, Heather N. Anderson, MD, J

Intangible benefits of volunteering with the Heart Rhythm Society

Jay A. Montgomery, MD, Dan M. Roden, MD, FHRS HeartRhythm Case Reports

Vagally mediated ventricular arrhythmia in Brugada syndrome

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation

Volume 10, Issue 4, Pages (April 2013)

Volume 6, Issue 3, Pages (March 2009)

Volume 8, Issue 1, Pages (January 2011)

HRS collaborates with leading medical societies to launch a voluntary laboratory accreditation program and drive quality improvement John D. Day, MD,

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation Yoshitaka Kimura, MD, Takeshi Aiba, MD, PhD, Tetsuo Sasano, MD,

Volume 9, Issue 1, Pages (January 2012)

Different rate-dependent responses between J waves and the notches on an epicardial local electrogram in a patient with idiopathic ventricular fibrillation

Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram

Gerald V Naccarelli, MD, Charles Antzelevitch, PhD

The use of noninvasive ECG imaging for examination of a patient with Brugada syndrome Maria Chaykovskaya, MD, Boris Rudic, MD, Alexey Tsyganov, MD, Elena.

Unusual severe hemodynamic failure associated with standard dose of intravenous flecainide for pharmacological cardioversion of atrial fibrillation Aref.

P wave and the development of atrial fibrillation

Early repolarization syndrome: A case report focusing on dynamic electrocardiographic changes before ventricular arrhythmias and genetic analysis Vern.

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome Maria J. Farag, BS, Joseph.

Volume 14, Issue 1, (January 2017)

Brugada-type Electrocardiographic Pattern Unmasked by Fever

Presentation transcript:

Volume 6, Issue 9, Pages 1335-1341 (September 2009) Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) Pieter G. Postema, MD, Christian Wolpert, MD, Ahmad S. Amin, MD, Vincent Probst, MD, PhD, Martin Borggrefe, MD, PhD, Dan M. Roden, MD, Silvia G. Priori, MD, PhD, Hanno L. Tan, MD, PhD, Masayasu Hiraoka, MD, PhD, Josep Brugada, MD, PhD, Arthur A.M. Wilde, MD, PhD Heart Rhythm Volume 6, Issue 9, Pages 1335-1341 (September 2009) DOI: 10.1016/j.hrthm.2009.07.002 Copyright © 2009 Heart Rhythm Society Terms and Conditions

Figure 1 Conversion of a normal ECG to a type 1 Brugada syndrome ECG during ajmaline challenge. Note the coved-type ST segments (arrows) in the right precordial ECG leads at peak ajmaline (note that V3 is placed in the third intercostal space above V1 [V1ic3], and V5 is placed in the third intercostal space above V2 [V2ic3]). Heart Rhythm 2009 6, 1335-1341DOI: (10.1016/j.hrthm.2009.07.002) Copyright © 2009 Heart Rhythm Society Terms and Conditions

Figure 2 Nonsustained ventricular tachycardia in a patient who was given flecainide for paroxysmal atrial fibrillation. Note the coved-type ST segments (arrow). The patient was diagnosed with Brugada syndrome during an ajmaline provocation test. Heart Rhythm 2009 6, 1335-1341DOI: (10.1016/j.hrthm.2009.07.002) Copyright © 2009 Heart Rhythm Society Terms and Conditions

Figure 3 Screenshot of the website www.brugadadrugs.org. Heart Rhythm 2009 6, 1335-1341DOI: (10.1016/j.hrthm.2009.07.002) Copyright © 2009 Heart Rhythm Society Terms and Conditions